Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASET-JAPAN prasugrel monotherapy after PCI with SYNERGY stent
jRCTs042200053Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prasugrel in acute coronary syndrome (ACS), Chronic Coronary Syndrome (CCS) and cardiac ischemia, sponsored by Boston Scientific Corporation. Started Dec 2020; status: completed.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)Chronic Coronary Syndrome (CCS)cardiac ischemia
Beyond the preview
Go deeper on jRCTs042200053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs042200053.